Is metformin more than an oral hypoglycaemic agent?
作者信息
Vague P
出版信息
Diabetes Metab. 2003 Sep;29(4 Pt 2):6S5-7. doi: 10.1016/s1262-3636(03)72782-7.
Abstract
摘要
相似文献
1
Is metformin more than an oral hypoglycaemic agent?
Diabetes Metab. 2003 Sep;29(4 Pt 2):6S5-7. doi: 10.1016/s1262-3636(03)72782-7.
2
Metformin: diamonds are forever.
Expert Opin Pharmacother. 2009 Oct;10(15):2395-7. doi: 10.1517/14656560903176453.
3
[Characteristic of metformin for treatment of impaired glucose tolerance].
Nihon Rinsho. 2005 Feb;63 Suppl 2:433-7.
4
[Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Ugeskr Laeger. 2009 May 4;171(19):1598-602.
5
Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61. doi: 10.1016/s1262-3636(03)72788-8.
6
Antiatherogenic properties of metformin: the experimental evidence.
Diabetes Metab. 2003 Sep;29(4 Pt 2):6S71-6. doi: 10.1016/s1262-3636(03)72790-6.
7
Metformin and vascular protection: a cardiologist's view.
Diabetes Metab. 2003 Sep;29(4 Pt 2):6S117-20. doi: 10.1016/s1262-3636(03)72796-7.
8
Metformin: a multitasking medication.
Diab Vasc Dis Res. 2008 Sep;5(3):156. doi: 10.3132/dvdr.2008.026.
9
Polycystic ovary syndrome.
N Engl J Med. 2005 Mar 24;352(12):1223-36. doi: 10.1056/NEJMra041536.
10
Insulin: thoroughly modern therapy.
Endocr Pract. 2004 May-Jun;10(3):289-90. doi: 10.4158/EP.10.3.289.
引用本文的文献
1
Nateglinide in combination with metformin in Chinese patients with type 2 diabetes mellitus: a post-marketing surveillance study.
Clin Drug Investig. 2013 Mar;33(3):185-91. doi: 10.1007/s40261-013-0054-4.
Zotero 插件